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Molecular Interaction of CD1b
with Lipoglycan Antigens
plex (MHC) class I molecules in sequence and interact
noncovalently with b2-microglobulin (b2m) (Calabi and
Bradbury, 1991). CD1 molecules are variously expressed
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shown to be facilitated by an acidic environment, and
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(Porcelli et al., 1992; Sieling et al., 1995). Thecytoplasmic
tail of thehuman CD1b molecule contains an endosomal
Summary targeting sequence that helps localize CD1b primarily
to late endosomes and MHC class II compartments
The ability of human CD1b molecules to present non- (MIICs), similar to the localization of MHC class II mole-
peptide antigens is suggested by the T cell recogni- cules (Sugita et al., 1996; Prigozy et al., 1997). In the
tion of microbial lipids and lipoglycans in the pres- MIIC, LAM and CD1b colocalize, suggesting that this is
ence of CD1b-expressing antigen-presenting cells. the location where LAM is loaded on to CD1b molecules
We demonstrate the high-affinity interaction of CD1b (Prigozy et al., 1997). The endosomal localization motif
molecules with the acyl side chains of known T cell is essential for antigen presentation by CD1b, indicating
antigens, lipoarabinomannan,phosphatidylinositol man- that trafficking of CD1b through endosomal/lysosomal
noside,and glucose monomycolate. Furthermore, CD1b± compartments is required for loading of antigen into
antigen binding was optimal at acidic pH, consistent CD1b (Jackman et al., unpublished data).
with the known requirement for endosomal acidifica- The goal of the present study was to investigate the
molecular mechanism by which lipid-containing anti-tion in CD1b-restricted antigen presentation. The
gens interact with CD1b by using direct biochemicalmechanism for CD1b±ligand interaction involves the
and biophysical measurements. We provide evidencepartial unfolding of the a helices of CD1b at acidic
for pH-dependent interaction of CD1b with LAM andpH, revealing a hydrophobic binding site that could
GMM, which is consistent with the requirement for endo-accommodate lipid. These data provide direct evi-
somal acidification in generating T cell responses todence that the CD1b molecule has evolved unique
lipid and lipoglycan antigens. The data obtained frombiochemical properties thatenable the binding of lipid-
studying the interaction of CD1b with nonpeptide anti-containing antigens from intracellular pathogens.
gens suggest a structural motif required for efficient
antigen loading.Introduction
ResultsThe human CD1 family consists of four known proteins,
which distantly resemble major histocompatibility com-
Stability of Soluble CD1b±b2m
To determine whether CD1b can physically bind to lipo-11 To whom correspondence should be addressed (e-mail: rmodlin
@medicine.medsch.ucla.edu). glycan antigens and to identify the mechanism for such
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of heterodimers were present in an aggregated form
(data not shown).
The CD1b±b2m heterodimers were assessed in terms
of thermostability and pH stability. The CD1b±b2m asso-
ciation was thermostable up to 508C, as compared with
class I HLA-A201±b2m heterodimers, which were ther-
mostable to 408C (Figure 1B). In addition, CD1b±b2m
heterodimers could be detected using conformation-
sensitive antibodies (see below). Therefore, the recom-
binant CD1b±b2m complexes are likely to be properly
folded.
MHC class I molecules have been shown to be acid-
labile (Parker and Strominger, 1985). We examined the
pH stability of CD1b±b2m heterodimers, which traffic to
endosomes and presumably bind antigen there, on the
assumption that the binding might be more stable at
acidic pH. Whereas HLA-A201±b2m complexes dissoci-
ate below pH 5.0 (Figure 1C), CD1b±b2m heterodimers
were found to be acid-stable even to pH 3.0, well below
the reported pH of acidified endosomes (Yamashiro and
Maxfield, 1987). We therefore conclude that the CD1b
heavy chain has evolved such that it can remain associ-
ated with b2m at the acidic pH of endosomal vesicles.
Some soluble class I molecules and recently mouse
CD1.1 have been shown to contain electron dense mate-
rial in the binding groove by X-ray crystallography (Zeng
et al., 1997), which appears to be lipid in nature (B.
Segelke and I. Wilson, personal communication). We
wanted to establish conditions in which the CD1b±b2m
stability would be assessed in the absence of any lipid,
given that newly purified CD1b±b2m heterodimers are
likely to be delivered to acidified endosomes without
bound ligand. Therefore, the pH stability studies per-
formed were done in the presence of 0.05% Tween 20.
This concentration of detergent was shown in the bind-
Figure 1. Stability of Purified CD1b±b2m Heterodimers ingstudies to besufficient to remove lipid antigensasso-
(A) SDS-PAGE of purified CD1b±b2m molecules followed by staining ciated with CD1b (see below), and it is unlikely that therewith Coomassie brilliant blue. In the first lane, a molecular weight
would be any antigen associated with CD1b under thesemarker was used as a reference. In the second lane, the upper band
conditions, although we cannot be certain they arecorresponds to the truncated CD1b, and the lower band corre-
sponds to the light-chain b2m. empty.
(B) Western blot analysis showing the amount of b2m associatedwith
the CD1b and HLA-A201 heavy chains after incubation at various
temperatures. CD1b±b2m and A201±b2m were incubated for 2 hr in Kinetics of Binding of CD1b to M. leprae LAM
13 PBS (pH 7.2) with 0.05% Tween 20 adjusted to the indicated
To investigate whether CD1b±b2m could interact directlytemperature. CD1b and A201 heavy chains were then precipitated
with a nonpeptide antigen and whether the binding waswith Ni-NTA resin, and samples were separated by a 15% SDS-
pH dependent, we chose to study the microbial lipogly-PAGE. The gel was blotted to nitrocellulose and the proteins visual-
ized using a mixture of mAbs 12CA5 (anti-HA epitope, reactive with can LAM, a previously identified antigen for CD1b-
both heavy chains) and BBM.1 (anti-b2m). restricted T cell responses in human infectious disease
(C) Western blot analysis showing the amount of b2m associated (Sieling et al., 1995). In addition, the large size of LAM
with the CD1b and HLA-A201 heavy chains after incubation at vari-
and its relatively high solubility in aqueous buffer wereous pHs. CD1b±b2m and A201±b2m were incubated for 2 hr in 13
ideal for physical studies. The ability of CD1b to bindPBS with 0.05% Tween 20adjusted to the indicated pH. The samples
LAM was measuredusing an evanescence wave sensor,were then treated the same as the samples in the temperature
stability experiment above. which uses the reflection of polarized light to measure
mass changes in real time. The integrity of the chip-
bound CD1b was demonstrated using conformation-
sensitive anti-CD1 monoclonal antibodies (mAb) (Figurean interaction, recombinant soluble CD1b±b2m hetero-
dimers were produced in Drosophila melanogaster (S-2) 2A). An anti-CD1b antibody showed binding to immobi-
lized CD1b, as evidenced by an additional increment incells, which have been shown to produce properly
folded and functional MHC class I molecules including response units (RU). An anti-CD1c antibody did not bind,
serving as a negative control.human leukocyte antigen (HLA)±A201±b2m heterodim-
ers (Jackson et al., 1992). CD1b±b2m heterodimers were Binding of LAM to immobilized CD1b was pH depen-
dent, detected below pH 5.0 and maximal at pH 4.0then purified by nickel affinity and anion exchange chro-
motography (Figure 1A). By gel filtration, less than 5% (Figures 2B and 2C). A201±b2m complexes did not bind
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Figure 2. Interaction of LAM with CD1b±b2m
(A) Binding of biotinylated CD1b to a strepta-
vidin-coated chip and the effect of sub-
sequent addition of an anti-CD1b mAb
(BCD1b3.1) and an anti-CD1c mAb (M241)
were measured in response units. Antibodies
(10 nM) were added to the chip in HBS (pH
7.4) at the indicated time.
(B) Sensorgrams showing pH-dependent
binding of 22 nM M. leprae LAM to surface-
bound CD1b.
(C) The response units of LAM binding to
CD1b (filled circles) versus HLA-A201 (open
circles) as a function of pH.
(D) Dissociation analysis of CD1b±LAM com-
plexes. Equilibration of the cuvette at pH 7.2
was carried out, followed by acidification at
pH 4.0, which causes a gross refractive index
change (r). LAM was added, and binding (b)
of approximately 200 RU was observed. Un-
bound LAM was washed out with equilibra-
tion buffer at either pH 7.2 or 4.0 for 30 min.
When the pH was reversed to 7.2, a second
refractive index change (R) was observed.
The difference (B) betweenthe RU at the base
of the refractive index change (110 RU) to the
end of data collection (210 RU) demonstrates
the stable binding of this ligand. The percent-
age of LAM associated with CD1b at pH 7.2
after 30 min is estimated as b/B (3100), ap-
proximately 50%.
LAM (Figure 2C), demonstrating the specificity of the faster than the kdiss observed with antigenic peptides
and MHC class I and class II molecules (Roche andCD1b±LAM interaction. The pH at which LAM binding
to CD1b was observed using the evanescence wave Cresswell, 1990; Corr et al., 1994). The CD1b±LAM equi-
librium binding constant (KD) was calculated from thesensor approximated the pH of late endosomes, the
compartment for MHC class II loading (MIIC) and lyso- kinetic data (KD 5 kdiss/kass) to be 3.2 6 1.0 3 1028 M).
Given the inherent technical limitations in using thesomes (Yamashiro and Maxfield, 1987).
The CD1b±LAM complex, once formed in acidified kinetic data from evanescent wave technology to calcu-
late binding constants (Schuck, 1996), we consider suchendosomes, would be expected to traffic to the cell
surface and be exposed to neutral pH. To determine measurements to be estimates of the true constants.
Nevertheless, we also calculated the KD by Scatchardwhether this change in pH would affect the CD1b±LAM
interaction, we bound LAM to CD1b at pH 4.0 and then analysis of the steady-state CD1b±LAM interaction. This
analysis gave KD values of 5.3 3 1028 M in one experi-washed the chip with equilibration buffer at pH 7.2 (Fig-
ure 2D). After 30 min at pH 7.2, approximately 50% of ment (Figure 3C) and 6.6 3 1028 M in another (data not
shown), similar to the KD value obtained from the kineticsthe LAM initially bound at pH 4.0 remained associated
with CD1b±b2m. These data suggest that the LAM±CD1b data. Therefore, the apparent KD for CD1b±LAM binding
is similar to high-affinity interactions between MHC mol-complex is sufficiently stable at neutral pH to permit
interaction with the appropriate T cell receptor (Matsui ecules and immunogenic peptides, which range from
1027 to 1029 M (Sette et al., 1994; Guercio et al., 1995).et al., 1997).
The binding kinetics for the CD1b±LAM interaction at Although there was batch-to-batch variation in the abil-
ity of LAM to bind CD1b, binding was also observedpH 4.0 were determined from data obtained using the
evanescence wave sensor. Various concentrations of with lipomannan, a molecule with a similar structure as
Mycobacterium leprae LAM were added to a CD1b- LAM except that it lacks the arabinan moiety (data not
coupled sensor chip, and the observed on-rates (kobs) shown).
were calculated by applying a single exponential model
to the initial phase of the association binding curves
pH-Induced Conformational Changes in CD1(Figure 3A). The association rate constant (kass), deter-
Structural studies of the mouse CD1.1 molecule havemined from a linear transformation of the data using a
revealed a probable antigen-binding groove, which iskobs versus C plot (where C is the LAM concentration),
bounded by two a-helical structures (Zeng et al., 1997).was calculated to be 5.9 6 1.1 3 104 M21´s21 (Figure
This groove is narrower and more hydrophobic than3B). We calculated the dissociation rate constant (kdiss)
those in MHC class I and class II molecules and mayby extrapolation of the kobs versus C plot to the y inter-
cept (kdiss 5 1.9 6 0.26 3 1023 s21), which is somewhat be suited to bind nonpeptide antigens (Zeng et al., 1997).
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Figure 4. Biophysical Analysis of Acidified CD1b Molecules by Cir-
cular Dichroism
(A) Far UV spectra of CD1b acidified with HCl from pH 7.0 to 3.0
showing a decrease in a-helical content with decreasingpH. Spectra
for 4.0 and 3.5 are nearly overlapping (pH 4.0 and 3.5).
(B) In a second experiment, the reversibility of pH effect on the
a-helical content of CD1b was measured. A sample at pH 4.0 and
3.0 was neutralized with NaOH to pH 7.2 and then analyzed. The
wavelength scans are an average of ten separate scans. Reproduc-
Figure 3. Kinetics and Binding Affinity of CD1b Association to LAM ible results were obtained from two separate batches of recombi-
nant CD1b for experiments shown in (A) and (B).(A) To determine the equilibrium constant, various concentrations
of LAM were incubated on a CD1b-coated IAsys chip at pH 4.0, and
effective binding and dissociation were observed in response units.
used to record changes in the a-helical content of pro-The same equilibrium buffer at pH 4.0 was used to wash the coated
teins. The calculated percent a-helical content of CD1bchip to measure the dissociation.
(B) Determination of the association rate constant (kass) by plotting at neutral pH is in good agreement with the structural
the observed on-rate (kobs) versus the concentration of LAM. kobs data for mouse CD1.1 (Zeng et al., 1997). A decrease
was calculated using the first-order equation (Rt 5 R0 1 E[1 2 in a-helical content was observed with decreasing pH,
e2kobst ]), where Rt is the response time, R0 is the initial response, E indicating that the a helices became partially denaturedis the extent of the change in response, and t represents time.
(Figure 4A). To assess whether the denaturation wasThe dissociation rate constant (kdiss) was extrapolated from the y
reversible, the CD1b molecules were acidified and thenintercept.
(C) Scatchard analysis was performed using extent of binding by neutralized to pH 7.0. Circular dichroism analysis indi-
plotting [bound LAM]/[free LAM] versus [bound LAM]. The KD was cated that the pH-induced denaturation was partially
determined as the negative inverse slope. reversible when the CD1b molecules were acidified to
pH 4.0 but irreverisbly denatured at pH 3.0 (Figure 4B).
These data correspond to the binding experiments indi-We surmised that CD1b is likely to have a structure
similar to mouse CD1.1, and we also reasoned that simi- cating that optimal binding was obtained at pH 4.0.
lar to class II molecules, CD1b might undergo a partial
denaturation at acidic pH in its a-helical structure. This ANS Association with Acidified CD1b
To determine whether the unfolding of the CD1b a-heli-pH-induced structural change could facilitate the CD1b±
antigen interaction, as hasbeen proposed for MHC class cal structures might facilitate interaction with a hy-
drophobic ligand, we measured the fluorescence emis-II molecules (Lee et al., 1992). To examine the conforma-
tion of soluble CD1b at acidic pH, we monitored the pH- sion spectrum of 1-anilino-naphthalene-8-sulfonic acid
(ANS) in the presence of CD1b. ANS is an environment-induced unfolding of CD1b±b2m by charting the ob-
served circular dichroic (CD) spectra response at 220 sensitive fluorescent probe used to study structural
changes in proteins (Goto and Fink, 1989). In a hy-nm. The spectral response at 220 nm is the molecular
ellipticity maximum for a helices and can therefore be drophobic environment, the ANS fluorescence intensity
Interaction of CD1b with Lipoglycan Antigens
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Figure 5. Fluorescence Emission Spectra of
ANS Incubated with Acidified and Subse-
quently Neutralized CD1b
(A) Wavelength scans were recorded for ANS
incubated with CD1b at various pH units,
showing increasing ANS binding with in-
creasing pH.
(B) ANS fluorescence could be blocked in a
dose-dependent manner by the preincuba-
tion of LAM. The various concentrations of
M. leprae LAM are indicated.
(C) Comparison of M. leprae LAM (3.0 mM)
inhibition of ANS fluorescence incubated with
either CD1b at pH 4.0 or HLA-DR1 at pH 5.0,
which are the optimal binding pHs.
increases, and the emission maximum shifts to shorter Specificity of the LAM±CD1b Interaction
The extent of ANS fluorescence observed with CD1b atwavelengths (Runnels et al., 1996). When CD1b was
acidic pH suggests that CD1b binds nonpeptide anti-incubated with ANS at pH 7.0, relatively little ANS fluo-
gens by interacting, in part, with fatty acid moieties. Torescence was observed (Figure 5A). The fluorescence
test this hypothesis, we attempted to block the CD1b±emission increased 10-fold upon acidification to pH 4.0.
LAM interaction with defined subunits of LAM, (FigureIn contrast, a control protein, hen egg lysozyme, had
6A) given that the evanescent wave sensor does notvirtually the same ANS fluorescence emission profile at
permit the directdetection of these low molecularweightpH 7.0 as it had at pH 4.0 (data not shown).
compounds. The CD1b±LAM interaction was not blockedThe increased ANS fluorescence at pH 4.0 could be
with deacyl LAM, which lacks the two fatty acid sideblocked in a dose-dependent manner by preincubation
groups (Figure 6C), indicating that the lipid moieties areof CD1b molecules with LAM (Figure 5B). At a 2-fold
essential for binding. The CD1b±LAM interaction wasmolar excess of LAM to CD1b, there was a 50% inhibi-
completely blocked by the addition of PIM2Rv, isolatedtion of ANS fluorescence. At a 20-fold molar excess of
from Mycobacterium tuberculosis H37Rv and reflectingLAM to CD1b, the level of ANS fluorescence was similar
the basic phosphoglycolipid core of LAM in that it isto that observed at pH 7.0, indicating complete inhibition
composed of two mannose units linked to the inositolof the increased ANS binding was achieved by LAM at
of phosphotidylinositol. We found that PIM2Rv inhibitedacidic pH (Figure 5B). Preincubation of CD1b with 20-
the binding of LAM to CD1b in a dose-dependent man-
fold molar excess of LAM, treated to remove the acyl
ner (Figure 6B). From these experiments, it was possible
chains (deacyl LAM), showed relatively little inhibition
to calculate a KD of 2.2 6 1.2 3 1027 M for the CD1b±of ANS fluorescence (data not shown). To determine the
PIM2Rv interaction (Figure 6C). PIM2Rv also inhibited thespecificity of the LAM inhibition of ANS fluorescence binding of ANS to CD1b at acidic pH (data not shown).
with CD1b, we repeated this experiment with a soluble Although the determination of binding constants should
MHC class II molecule, HLA-DR1. Under mild detergent only be considered as estimates, the measurements do
conditions that stabilized the purified full-length HLA- reflect which types of molecules bind to CD1b and which
DR1, LAM significantly inhibited the ANS fluorescence do not. Nevertheless, the lower affinity of the CD1b±
of CD1b and only slightly blocked the ANS fluorescence PIM2Rv interaction as compared with the CD1b±LAM
of DR1 (Figure 5C). These data suggest that ANS can interaction may be due to decreased solubility of this
detect a hydrophobic binding site of CD1b exposed compound in aqueous solution; however, we cannot
at acidic pH, which could accommodate hydrophobic exclude a role for carbohydrate residues in enhancing
ligands. Furthermore, the mechanism for antigen load- the binding to CD1b. These results suggest that the
ing involves a pH-dependent conformational change of arabinose portion and most of the mannose core are not
the CD1b±b2m heterodimer, which reveals the hydro- required for binding of lipoglycan molecules to CD1b.
To obtain direct evidence for the binding of PIM2 tophobic binding site.
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Figure 6. CD1b Binds to the Lipid-Containing Portions of M. leprae LAM and Synthetic PIM
(A) Structural model of LAM and its derivatives. LAM contains an arabinan head, a branched mannan core, and a phosphatidylinositol unit
most often including tuberculostearic acid (branched C:19) and palmitic acid (C:16). No major structural difference exists between M. leprae
PIM2 and M. tuberculosis PIM2Rv.
(B) IAsys sensorgrams depicting the binding of M. leprae LAM to a CD1b-coated chip preincubated with various concentrations of purified
M. tuberculosis PIM2Rv as indicated.
(C) Percent inhibition of LAM binding by preincubating a CD1b-coated IAsys chip with PIM2Rv (filled circles) and deacyl LAM (open circles)
at pH 4.0.
(D) Biacore sensorgrams of various concentrations of synthetic PIM2 incubated on a CD1b-coated sensor chip at pH 4.0. The same equilibrium
buffer at pH 4.0 was used to wash the coated chip to measure the dissociation.
CD1b, we utilized surface plasmon resonance, which strongly dependent on the length of the proximally
also usespolarized light to detectmolecular interactions branched acyl function, but they are dependent on the
but can detect smaller molecules than the evanescent presence of the proximal and b-OH group, as well as
wave sensor. To ensure the purity and homogeneity the precise stereochemical configuration of the glucose
of the ligand, we studied a synthetic PIM2 (sPIM2) that residue (Moody et al., 1997). These data have led to the
contains two stearic acid (C:18) moieties as the fatty hypothesis that the more distal nonpolar lipid portion
acid function. We found that sPIM2 bound to CD1b in a of GMM binds to the hydrophobic groove of CD1b,
dose-dependent manner (Figure 6D). The association allowing recognition of the carbohydrate portion and
and dissociation curves were obtained to determine the proximal mycolic acid polar substituents by T cells.
equilibrium constant. The association phase was fitted Therefore, we studied the interaction between CD1b
to a single exponential model and the kass calculated to with naturally occurring GMM and its synthetic analogs
be 2.7 6 1.0 3 102 M21´s21. The dissociation phase was (Figure 7A). The binding of GMM to CD1b was pH depen-
also fitted to a single exponential model and the kdiss dent, occurring at pH 4.0 but not at pH 7.0 (Figure 7B).
measured to be 1.8 6 0.2 3 1024 s21. From these data,
A synthetic GMM (sGMM) that contained a shorter
the CD1b±sPIM2 equilibrium binding constant (KD) was branched acyl chain also bound at pH 4.0 but not at pH
calculated to be 6.6 6 4 3 1027 M. This is similar to the
7.0. sGMM bound to CD1b but not to chips coated withvalue obtained when PIM2Rv purified from M. tuberculo- HLA-A2 or HLA-DR1, which served as negative controlssis was used to inhibit LAM binding (Figure 6C). Because
(Figure 7C). Glucose-6-o-triacontanoate (G6T), whichnatural PIM2Rv contains primarily a modified stearic
differs from GMM by possessing a single unbranched(C:18) and palmitic acid (C:16), the data indicate that
acyl chain but has almost the same number of aliphaticPIM2 binding is not highly sensitive to subtle changes
carbons as sGMM, did not bind to CD1b (Figure 7A).in acyl chain length. These data demonstratethe interac-
These binding data, using a second independent classtion of CD1b with a structurally defined fully synthetic
of well-characterized CD1b-presented antigens, sup-lipoglycan molecule. Similar datausing surface plasmon
port the hypothesis that CD1b binds lipid antigens. Fur-resonance were obtained for PIM2Rv (data not shown).
thermore, the binding properties shown here were fully
consistent with previous functional studies on T cellInteractions of CD1b with GMM
recognition of these compounds (Moody et al., 1997).Analysis of CD1b-restricted T cell responses to GMM
indicates that presentation and recognition are not To determine whether GMM and LAM bind to thesame
Interaction of CD1b with Lipoglycan Antigens
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Figure 7. Binding of GMM to CD1b
(A) Structures of GMM and its derivatives.
Purified GMM from M. plei contains a 78-car-
bon unsaturated branched acyl chain linked
to carbon 6 of glucose. sGMM is identical to
the purified GMM in its linkage to glucose
but contains only a 32-carbon saturated acyl
chain. G6T has a composition similar to that
of sGMM, with a 30-carbon saturated acyl
chain linked to glucose through its carbon 6,
but its lipid component lacks the a-branched
and b-hydroxyl structural characteristic of
mycolic acids.
(B) Biacore sensorgram of purified and sGMM
on a CD1b-coated sensor chip at pH 4.0 or
7.0 and G6T at pH 4.0.
(C) Binding of sGMM to CD1b, but not to A201
or DR1, as determined by Biacore sen-
sorgram.
(D) Inhibition of sPIM2 binding by preincubat-
ing a CD1b-coated Biacore chip with none,
292 mM GMM, or 292 mM G6T at pH 4.0. Ex-
cess competitor was washed with the equili-
bration buffer (pH 4.0) prior to the addition of
5 mM sPIM2. Preincubation of molecules and
subsequent addition of sPIM2 are indicated.
site on CD1b, we performed competition studies by se- that involves the partial unfolding of the a helices of
CD1b at acidic pH, revealing a hydrophobic binding site,quentially adding to the CD1b-coated chip sGMM fol-
lowed by a short wash and then sPIM2. We observed which could accommodate lipid moieties. The present
data provide direct evidence that the interaction be-an increase of 50 RU when sGMM was injected on to
the CD1b-coated chip compared to no increase when tween nonpeptide antigen and CD1 is stable and of
high affinity and provide insight into the mechanism ofG6T was injected. Upon the subsequent addition of
sPIM2, we could not detect any binding after sGMM; antigen loading.
Our data provide a model for explaining the novelhowever, after G6T was injected the sPIM2 showed re-
sponse units equal to the no competitor control. These interaction of an antigen-presenting molecule with de-
fined lipoglycans and glycolipids. Previous studies indi-surface plasmon resonance experiments indicated that
GMM, but not G6T, could inhibit the binding of sPIM2 cated that both LAM and CD1b traffic to late endo-
somes, including MIICs (Sugita et al., 1996; Prigozy etto CD1b (Figure 7D). These data further confirm the
structural specificity of antigen±CD1b interaction. Fur- al., 1997). Acidificationof these compartmentsmay facil-
itate the loading of antigens such as LAM into CD1b,thermore, the ability of GMM to inhibit the binding of
sPIM2 to CD1b suggest that these two distinct classes because under acidic conditions the a helices of CD1b
partially unfold, which exposes a hydrophobic bindingof antigen bind to the same site, likely to be the hy-
drophobic groove of CD1b based on our knowledge of site able to accommodate the fatty acid side chains of
LAM and other lipid-containing antigens. Presentationthe crystal structure of mouse CD1.1 (Zeng et al., 1997).
of another lipid antigen, GMM, also requires endosomal
acidification (Moody et al., 1997). Furthermore, presen-Discussion
tation of GMM requires trafficking of CD1b to endo-
somes, because deletion of the cytoplasmic endosomalIn the present study, we demonstrate the direct physical
interaction of CD1b molecules with known T cell anti- targeting sequence markedly diminishes antigen pre-
sentation to T cells (Jackman et al., unpublished data).gens, LAM, PIM, and GMM. The high-affinity binding of
LAM and GMM to CD1b was dependent upon the acyl The pH-dependent binding of both LAM and GMM to
CD1b indicates that the acidic environment of endo-side chains of the antigens. Antigen loading was optimal
at acidic pH, consistent with previous studies, which somes may be a universal requirement for efficient load-
ing of lipoglycan antigens into CD1b molecules.indicate that endosomal acidification is necessary for
CD1b-restricted antigen presentation (Porcelli et al., This model raises questions as to the mechanism by
which the T cell receptor contacts antigen±CD1b com-1992; Sieling et al., 1995). Biophysical measurements of
CD1b indicate a pH-dependent conformational change plexes and whether the antigen requires processing for
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as described (Jackson et al., 1992; Matsumura et al., 1992). In brief,such contacts to occur. Because of the large size of
the transfected cells were grown in serum-free media (Insect-LAM, we consider it unlikely that the T cell receptor binds
Xpress, BioWhittaker, Walkersville, MD) to 4 3 106 cells/ml, and thenboth the unprocessed LAM molecule and the CD1b a
induced with 1 mM CuSO4. The cells were incubated for 3 days athelices in a fashion similar to the peptide antigen MHC- 258C, and then the supernatant was collected. The CD1b hetero-
contacts made by the T cell receptor on CD4 and CD8 dimer was purified using nitriloacetic acid (NTA)±Ni resin (Qiagen,
Chattsworth, CA) and anion exchange (Hitrap Q, Pharmacia, Upsala,T cells. Instead, it is more likely that LAM requires pro-
Sweden) chromatographies. A201±b2m complexes were judged tocessing of its large carbohydrate moiety to permit such
be properly folded because they reacted with a conformation-sensi-contact. Therefore, the dependence on endosomal acid-
tive antibody (W6/32, American Type Culture Collection, Rockville,ification for efficient presentation of LAM to T cells may
MD) and bound specifically to known A2-binding peptides.
reflect both a requirement for LAM to enter appropriate To increase the protein yield, we also produced protein using the
processing compartments, as well as the need for CD1b baculovirus system. The cDNAs for both human CD1b, including
the hexahistidine tag and HA tag andhuman b2m, wereenzymaticallyto undergo conformational changes for antigen loading.
digested from the pRMHa3 vector (described above) and ligatedIn contrast, GMM has a small hydrophilic group, and
into the pBAC vector (Invitrogen, San Diego, CA). The proteins weremodification of its structure may not be required for T
expressed under the control of two polyhedron promotors. Trans-cell recognition. In this case, the requirement for endo-
fection was done in Sf 21 cells (Invitrogen) using the manufacturer's
somal acidification may only reflect a need for low pH recommended calcium phosphate procedure. The CD1b±b2m
on the efficiency of antigen loading. heterodimer was produced using Hi 5 cells (Invitrogen) grown in
serum-free media (Insect-Xpress). The cells were infected at an MOIAt present, three classes of CD1b-restricted T cell
of approximately 10:1 and incubated at 258C for 5 days. The proteinantigens have been identified: free mycolic acids; man-
was purified as described above. HLA-DR1 was purified from thenose containing phosphatidylinositides, including LAM
EBV-transformed homozygous LG2 B cell line (DRB1*0101) usingand its structurally analogous biosynthetic precursors;
an mAb LB3.1 (Stern and Wiley, 1992) immunoaffinity column as
and glycosylated mycolates, including GMM. All these previously described (Jensen, 1991).
antigens contain either dual acyl chains as present in
LAM and PIM2 or a proximally branched single acyl chain Gel Electrophoresis
SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was per-as present in GMM, suggesting a structural motif for
formed using a 15% acrylamide gel. The gel was stained with Coo-antigen binding to CD1b. The crystal structure of mouse
massie brilliant blue G-250 (Bio-Rad, Hercules, CA).CD1.1 demonstrates a hydrophobic binding groove that
could accommodate acyl chains (Zeng et al., 1997). Our
Stability Assays of b2m/Heavy-Chain Complexesstudy provides direct evidence that at least two of the The temperature stability assay was performed in 100 ml of phos-
known classes of biologically relevant lipid antigens phate buffered saline (PBS) (pH 7.2) with 0.05% Tween 20 (PBST).
bind to an identical site on CD1b, which most likely is the One microgram of either purified CD1b±b2m (CD1b) or A201±b2m
(A201) was incubated for 2 hr at the indicated temperature. The pHhydrophobic binding groove. Previous studies suggest
stability assay was performed in 100 ml of PBS with 0.05% Tweenthat the specificity of CD1-restricted T cell recognition
20 (PBST). One microgram of either purified CD1b±b2m (CD1b) oris directed against the hydrophilic region of these non-
A201±b2m (A201) was incubated for 2 hr at the indicated pH. CD1bpeptide antigens, the mannose portion of LAM, and the or A201 heavy chains were recovered by incubating with 5 ml of Ni-
b-hydroxyl portion of GMM (Beckman et al., 1994; Sie- NTA agarose beads (Qiagen) overnight at 48C. Beads were then
ling et al., 1995; Moody et al., 1997). These investigations washed with PBST, 10 mM imidazole, and bound molecules were
eluted with 50 ml of PBS and 150 mM imidazole. Samples wereprovide a foundation for further exploration of the mech-
loaded onto SDS-15% polyacrylamide gels. For Western blot analy-anism by which CD1 is able to acquire and present this
sis, the proteins were blotted from the SDS-PAGE to nitrocellulosenovel class of nonpeptide antigens that are normally
and incubated with 12CA5 (anti-HA epitope mAb; a gift from A.
sequestered in cell walls and membranes of pathogenic Berk, University of California, Los Angeles), which binds native and
organisms. More importantly, the identification of the denatured class I heavy chains and BBM.1 (anti-b2m mAb, Ameri-
structural characteristic required for binding to CD1 de- can Type Culture Collection) to determine the extent of association
with b2m.lineates the universe of candidate antigens that could
elicit a CD1-restricted T cell response in host defense
Antigensand in immunopathologic conditions.
Purified M. leprae LAM, deacyl LAM, and M. tuberculosis strain
H37Rv PIM2 were prepared as previously described (Hunter and
Brennan, 1990; Chatterjee et al., 1992a, 1992b; Sieling et al., 1995).Experimental Procedures
After the final stage of purification on an octyl-Sepharose column
to remove the free glycan contaminants (Chatterjee et al., 1992a),CD1b Expression and Purification
CD1b±b2m heterodimers were produced using D. melanogaster S-2 fractions containing LAM and LM were pooled and size-fractionated
on a Sephacryl S-200 column. Fractions were pooled according tocells as well as the baculovirus system. These systems have been
previously used for the production of CD1 molecules (Jackson et their SDS-PAGE (periodic acid Schiff staining) and dialyzed. Mono-
saccharide composition analysis of an aliquot of LAM gave anal., 1992) and HLA molecules (Kappler et al., 1994).
Oligonucleotides and a full-length human CD1b cDNA clone were Ara:Man ratio of 2:1, comparable to our earlier data (Khoo et al.,
1995). The LAM-specific mAb CS-35 was also used for the positiveused to PCR-amplify a modified CD1b cDNA (Aruffoand Seed, 1989)
encoding the extracellular domains followed by the hemagglutinin recognition of LAM. All preparations contained less than 100 pg/ml
of endotoxin as measured by Limulus amoebocyte lysate commer-(HA) epitope (Wilson et al., 1984) and a hexahistidine tag cloned
into the pRMHa3 vector. This construct, human b2m-pRMHa3 (gift cial assay (BioWhittaker). Deacylation of LAM was carried out using
established procedures (Chatterjee et al., 1992a). LAM was sus-of J. E. Miller, IXSYS), and a selection plasmid pUChsneo (Elliott et
al., 1991) were cotransfected by calcium phosphate into D. melano- pended in 0.1 N NaOH and kept at 378C overnight. The solution was
neutralized and partitioned with organic solvents to remove thegaster embryo (S-2) (a gift from L. Zipursky, University of California,
Los Angeles) cells and stable transfectants established as described liberated fatty acids. The aqueous layer was desalted (H1 resins) and
dried. To purify PIM2Rv preparative thin-layered chromatography of(Jackson et al., 1992). Secreted CD1b±b2M and HLA-A201±b2m (a
gift from M. Jackson, Scripps Institute, La Jolla, CA) were purified the chloroform/methanol extract was performed, followed by
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scraping of the bands and eluting with chloroform/methanol from with 0.05% 1-S-octyl-b-D-thioglucopyranoside (Pfanstiehl, Wauke-
gan, IL); the pH was adjusted with HCl; and incubation was con-the silica (Datta et al., 1991). Synthetic PIM2 was synthesized as
previously described in detail (Watanabe et al., 1997). sGMM and ducted for 30 min at room temperature. Then, 20 mM ANS was
added and the samples analyzed as described above.G6T were synthesized by coupling the free carbohydrate to position
6 of glucose as described (Moody et al., 1997). Natural GMM was
purified from chloroform/methanol (2:1) extracts of Mycobacterium Competitive Binding Assay
phlei eluted from a silica column in 30% acetone in chloroform as The KD of the CD1b±PIM2 interaction was estimated from the specific
described (Moody et al., 1997). competition of binding using fragments of the LAM molecule as
competitors. To the CD1b-coated IAsys cuvette, various concentra-
tions of purified M. tuberculosis (strain H37Rv) PIM2 (PIM2Rv) andEvanescent Wave Sensor
deacyl LAM were added for 15 min in equilibration buffer (10 mMSoluble CD1b was biotinylated using biotin-labeled 1-biotinamido-
NaOAc and 75 mM NaCl [pH 4.0]) and washed with equilibration4-(49-[maleimidomethyl] cyclohexanecarboxamido) butane (biotin-
buffer, and then 22 nM M. leprae LAM was added to the chip andBMCC) from Pierce (Rockford, IL). Biotinylated CD1b molecules
the response units measured. The molecular weight of PIM2Rv iswere immobilized to an avidin-coated IAsys chip from Fisons Tech-
below the detection limit of the instrument, and therefore directnology (Cambridge, England) at 258C. Neutravidin (Pierce) was im-
measurement was unattainable. The KD estimation for PIM2Rv wasmobilized using standard amine chemistries (Corr et al., 1994). Bio-
determined using the method of Cheng and Prusoff (1973). Thetinylated CD1b was added at a concentration of 0.44 mM, which
molecular weight of M. leprae deacyl LAM is sufficient to detectgenerally yielded 200±400 RU. pH-dependent binding to CD1b was
binding, but no binding was observed when deacyl LAM was addedassessed by adding 22 nM M. leprae LAM in 10 mM NaOAc and 75
to a CD1b-coated cuvette.mM NaCl (equilibration buffer) at different pHs. Kinetic studies were
performed by adding various concentrations of M. leprae LAM in
equilibration buffer (pH 4.0). Evaluation of the data was performed Direct Binding of Small Ligands by Surface
using the IAsys fast-fit program and choosingsingle or double expo- Plasmon Resonance
nential models to best fit the curve. Direct determination of the KD Experiments were performed on a Biacore X (Biacore, Piscataway,
for CD1b±LAM interaction was also determined. The dissociation NJ). Purified soluble CD1b was biotinylated as described above and
constant for CD1b with M. leprae LAM was analyzed under equilibra- immobilized to a streptavidin-coated Biacore chip according to the
tion (steady-state) conditions.Extent of binding (from the IAsys data) Biacore standard methods. Biotinylated CD1b was injected at 5 ml/
was converted from response units to nanomoles by the manufac- min at a concentration of 0.44 mM, which generally yielded 2500
turer's recommended conversion (163 ng/RU) for protein±protein RU. Kinetic studies were performed by injecting various concentra-
interactions. The concentration of LAM bound to the CD1b chip tions of synthetic PIM2 in equilibration buffer (pH 4.0) at a flow rate
versus the initial LAM concentration (bound/free) was plotted as a of 10 ml/min to gather the data for the association and washed
function of the concentration of LAM bound to the CD1b cuvette at with equilibration buffer (pH 4.0) to measure the dissociation phase.
each LAM concentration (bound). The KD was determined from the Evaluation of the data was performed using the BiaEvaluation soft-
extent of LAM binding to the CD1b-coated chip at equilibrium, and ware and choosing a single exponential model (A 1 B↔AB) to best
a standard Scatchard plot analysis was performed. The KD was fit the curve.
determined as the inverse slope of the line. To a CD1b-coated Biacore chip, 292 mM sGMM or 292 mM purified
M. phlei GMM at pH 7.0 or 4.0 was injected at a flow rate of 10 ml/
min. To determine specificity of the binding, 292 mM sGMM andCircular Dichroic Spectral Analysis
292 mM G6T were preincubated onto a CD1b sensor chip in theCircular dichroic measurements were performed in a Jasco 600
equilibration buffer at pH 4.0.The chip was washed with equilibrationcircular dichroic spectropolarimeter (Jasco, Tokyo, Japan) using a
buffer, and then 5 mM sPIM2 was injected. These experiments werequartz cuvette with a pathlength of 0.5 cm at 258C (Lee et al., 1992).
repeated twice with two different CD1b-coated sensor chips.The data are reported as the average of 10 scans at 50 nm/min with
a 0.1 nm step resolution. Spectra were recorded in the far-UV at a
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